C-MYB transcription factor network

No Pathway Network information available for C-MYB transcription factor network

Pathways in the C-MYB transcription factor network SuperPath

#	Name	Source	Genes
1	C-MYB transcription factor network	PubChem	ADA ADORA2B ANPEP ATP2B1 BCL2 BIRC3 CA1 CASP6 CBX4 CCNA1 CCNB1 CCND1 CD34 CD4 CDK6 CDKN1A CDKN1B CDKN2A CEBPA CEBPB CLTA COL1A2 COPA CREBBP CSF1R ELANE ETS1 ETS2 GATA1 GATA3 GSTM1 H2AZ1 HES1 HIPK2 HSPA5 HSPA8 IQGAP1 KIT KITLG LECT2 LEF1 LYZ MAD1L1 MAF MAP3K7 MAT2A MCM4 MPO MYB MYC MYF6 MYOD1 NCOR1 NLK NRAS PAX5 PIAS3 PIM1 PPID PPP3CA PRTN3 PTCRA PTGS2 RAG2 SIN3A SKI SLC1A5 SLC25A3 SMARCA2 SND1 SP1 SPI1 TFEC TOM1 TRIM28 UBE2I WNT1 YEATS4 ZFHX3 ZFPM1 (see all 80) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	MYF6	Myogenic Factor 6	Protein Coding	1
2	LECT2	Leukocyte Cell Derived Chemotaxin 2	Protein Coding	1
3	H2AZ1	H2A.Z Variant Histone 1	Protein Coding	1
4	TOM1	Target Of Myb1 Membrane Trafficking Protein	Protein Coding	1
5	TFEC	Transcription Factor EC	Protein Coding	1
6	PPID	Peptidylprolyl Isomerase D	Protein Coding	1
7	SLC25A3	Solute Carrier Family 25 Member 3	Protein Coding	1
8	KITLG	KIT Ligand	Protein Coding	1
9	MYOD1	Myogenic Differentiation 1	Protein Coding	1
10	WNT1	Wnt Family Member 1	Protein Coding	1
11	CD34	CD34 Molecule	Protein Coding	1
12	SMARCA2	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 2	Protein Coding	1
13	PPP3CA	Protein Phosphatase 3 Catalytic Subunit Alpha	Protein Coding	1
14	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	1
15	ATP2B1	ATPase Plasma Membrane Ca2+ Transporting 1	Protein Coding	1
16	PIM1	Pim-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
17	LEF1	Lymphoid Enhancer Binding Factor 1	Protein Coding	1
18	RAG2	Recombination Activating 2	Protein Coding	1
19	LYZ	Lysozyme	Protein Coding	1
20	BIRC3	Baculoviral IAP Repeat Containing 3	Protein Coding	1
21	PAX5	Paired Box 5	Protein Coding	1
22	GATA1	GATA Binding Protein 1	Protein Coding	1
23	ZFHX3	Zinc Finger Homeobox 3	Protein Coding	1
24	SPI1	Spi-1 Proto-Oncogene	Protein Coding	1
25	ZFPM1	Zinc Finger Protein, FOG Family Member 1	Protein Coding	1
26	MAF	MAF BZIP Transcription Factor	Protein Coding	1
27	CSF1R	Colony Stimulating Factor 1 Receptor	Protein Coding	1
28	YEATS4	YEATS Domain Containing 4	Protein Coding	1
29	CD4	CD4 Molecule	Protein Coding	1
30	SND1	Staphylococcal Nuclease And Tudor Domain Containing 1	Protein Coding	1
31	ANPEP	Alanyl Aminopeptidase, Membrane	Protein Coding	1
32	CBX4	Chromobox 4	Protein Coding	1
33	HIPK2	Homeodomain Interacting Protein Kinase 2	Protein Coding	1
34	TRIM28	Tripartite Motif Containing 28	Protein Coding	1
35	PIAS3	Protein Inhibitor Of Activated STAT 3	Protein Coding	1
36	MCM4	Minichromosome Maintenance Complex Component 4	Protein Coding	1
37	CDK6	Cyclin Dependent Kinase 6	Protein Coding	1
38	CCNA1	Cyclin A1	Protein Coding	1
39	ETS2	ETS Proto-Oncogene 2, Transcription Factor	Protein Coding	1
40	ETS1	ETS Proto-Oncogene 1, Transcription Factor	Protein Coding	1
41	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	1
42	MAD1L1	Mitotic Arrest Deficient 1 Like 1	Protein Coding	1
43	GATA3	GATA Binding Protein 3	Protein Coding	1
44	NLK	Nemo Like Kinase	Protein Coding	1
45	MAP3K7	Mitogen-Activated Protein Kinase Kinase Kinase 7	Protein Coding	1
46	PTCRA	Pre T Cell Antigen Receptor Alpha	Protein Coding	1
47	CCND1	Cyclin D1	Protein Coding	1
48	ADORA2B	Adenosine A2b Receptor	Protein Coding	1
49	SKI	SKI Proto-Oncogene	Protein Coding	1
50	COL1A2	Collagen Type I Alpha 2 Chain	Protein Coding	1
51	CASP6	Caspase 6	Protein Coding	1
52	BCL2	BCL2 Apoptosis Regulator	Protein Coding	1
53	UBE2I	Ubiquitin Conjugating Enzyme E2 I	Protein Coding	1
54	SIN3A	SIN3 Transcription Regulator Family Member A	Protein Coding	1
55	MYB	MYB Proto-Oncogene, Transcription Factor	Protein Coding	1
56	PRTN3	Proteinase 3	Protein Coding	1
57	ELANE	Elastase, Neutrophil Expressed	Protein Coding	1
58	IQGAP1	IQ Motif Containing GTPase Activating Protein 1	Protein Coding	1
59	SP1	Sp1 Transcription Factor	Protein Coding	1
60	CEBPB	CCAAT Enhancer Binding Protein Beta	Protein Coding	1
61	CEBPA	CCAAT Enhancer Binding Protein Alpha	Protein Coding	1
62	CREBBP	CREB Binding Lysine Acetyltransferase	Protein Coding	1
63	HES1	Hes Family BHLH Transcription Factor 1	Protein Coding	1
64	NCOR1	Nuclear Receptor Corepressor 1	Protein Coding	1
65	HSPA8	Heat Shock Protein Family A (Hsp70) Member 8	Protein Coding	1
66	COPA	Coat Protein Complex I Subunit Alpha	Protein Coding	1
67	CLTA	Clathrin Light Chain A	Protein Coding	1
68	SLC1A5	Solute Carrier Family 1 Member 5	Protein Coding	1
69	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	1
70	HSPA5	Heat Shock Protein Family A (Hsp70) Member 5	Protein Coding	1
71	CA1	Carbonic Anhydrase 1	Protein Coding	1
72	CCNB1	Cyclin B1	Protein Coding	1
73	KIT	KIT Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	1
74	ADA	Adenosine Deaminase	Protein Coding	1
75	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
76	CDKN1B	Cyclin Dependent Kinase Inhibitor 1B	Protein Coding	1
77	PTGS2	Prostaglandin-Endoperoxide Synthase 2	Protein Coding	1
78	GSTM1	Glutathione S-Transferase Mu 1	Protein Coding	1
79	MPO	Myeloperoxidase	Protein Coding	1
80	MAT2A	Methionine Adenosyltransferase 2A	Protein Coding	1

Disorders associated with C-MYB transcription factor network SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Acute basophilic leukemia	Enrichment	GATA1, MYB	4.46
2	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	BCL2, MYC	3.99
3	Precursor t-cell acute lymphoblastic leukemia	Enrichment	CDKN2A, MYB, MYC	3.49
4	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative	Enrichment	ADA, RAG2	3.47
5	Acute myeloid leukemia with t(8;21)(q22;q22) translocation	Enrichment	CEBPA, KIT	3.47
6	Myopathy, centronuclear, 1	Enrichment	MYF6, MYOD1	3.29
7	Testicular germ cell tumor	Enrichment	KIT, KITLG	3.29
8	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A, CDKN1B	3.15
9	Omenn syndrome	Enrichment	ADA, RAG2	2.82
10	Leukemia, acute myeloid	Enrichment	CEBPA, KIT, NRAS	2.78
11	Leukemia, acute lymphoblastic	Enrichment	CDKN2A, PAX5	2.74
12	Lip and oral cavity carcinoma	Enrichment	CDKN2A, KIT	2.66
13	Osteogenesis imperfecta, type iv	Enrichment	COL1A2, WNT1	2.59
14	Alzheimer's disease	Enrichment	CSF1R, MPO	2.59
15	Protein-deficiency anemia	Enrichment	GATA1, NRAS	2.59
16	Osteoporosis	Enrichment	COL1A2, WNT1	2.53
17	Osteogenesis imperfecta, type iii	Enrichment	COL1A2, WNT1	2.46
18	Alzheimer disease, familial, 1	Enrichment	CSF1R, MPO	2.36
19	Cardiospondylocarpofacial syndrome	Enrichment	MAP3K7	2.23
20	Ehlers-danlos syndrome, cardiac valvular type	Enrichment	COL1A2	2.23
21	Anemia, congenital, nonspherocytic hemolytic, 9	Enrichment	GATA1	2.23
22	Thrombocytopenia, x-linked, with or without dyserythropoietic anemia	Enrichment	GATA1	2.23
23	Thrombocytopenia with beta-thalassemia, x-linked	Enrichment	GATA1	2.23
24	Cataract 21, multiple types	Enrichment	MAF	2.23
25	Mastocytosis, cutaneous	Enrichment	KIT	2.23
26	Hyperpigmentation with or without hypopigmentation, familial progressive	Enrichment	KITLG	2.23
27	Microcephaly 12, primary, autosomal recessive	Enrichment	CDK6	2.23
28	Melanosis, neurocutaneous	Enrichment	NRAS	2.23
29	Noonan syndrome 6	Enrichment	NRAS	2.23
30	Shprintzen-goldberg craniosynostosis syndrome	Enrichment	SKI	2.23
31	Frontometaphyseal dysplasia 2	Enrichment	MAP3K7	2.23
32	Ectodermal dysplasia 17 with or without limb malformations	Enrichment	LEF1	2.23
33	Agammaglobulinemia 10, autosomal dominant	Enrichment	SPI1	2.23
34	Intellectual developmental disorder, autosomal dominant 66	Enrichment	ATP2B1	2.23
35	Immunodeficiency 85 and autoimmunity	Enrichment	TOM1	2.23
36	Developmental and epileptic encephalopathy 91	Enrichment	PPP3CA	2.23
37	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	Enrichment	PPP3CA	2.23
38	Combined osteogenesis imperfecta and ehlers-danlos syndrome 2	Enrichment	COL1A2	2.23
39	Anemia, x-linked, with or without neutropenia and/or platelet abnormalities	Enrichment	GATA1	2.23
40	Okt4 epitope deficiency	Enrichment	CD4	2.23
41	Ayme-gripp syndrome	Enrichment	MAF	2.23
42	Bone mineral density quantitative trait locus 16	Enrichment	WNT1	2.23
43	Immunodeficiency 54	Enrichment	MCM4	2.23
44	Skin/hair/eye pigmentation, variation in, 7	Enrichment	KITLG	2.23
45	Atrial fibrillation, familial, 8	Enrichment	ZFHX3	2.23
46	Neuroendocrine tumor	Enrichment	CDKN1B	2.23
47	Congenital myopathy 17	Enrichment	MYOD1	2.23
48	Immunoglobulin light chain amyloidosis	Enrichment	LYZ	2.23
49	Autoinflammation and autoimmunity, systemic, with immune dysregulation	Enrichment	COPA	2.23
50	Blepharophimosis-impaired intellectual development syndrome	Enrichment	SMARCA2	2.23
51	Amyloidosis, hereditary systemic 5	Enrichment	LYZ	2.23
52	Menke-hennekam syndrome 1	Enrichment	CREBBP	2.23
53	Brain abnormalities, neurodegeneration, and dysosteosclerosis	Enrichment	CSF1R	2.23
54	Immunodeficiency 79	Enrichment	CD4	2.23
55	Chronic mast cell leukemia	Enrichment	KIT	2.23
56	Deafness, autosomal dominant 69	Enrichment	KITLG	2.23
57	Acute megakaryoblastic leukemia in children with down syndrome	Enrichment	GATA1	2.23
58	Recombinase activating gene 2 deficiency	Enrichment	RAG2	2.23
59	Cdkn2a cancer predisposition	Enrichment	CDKN2A	2.23
60	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition	Enrichment	MAD1L1	2.23
61	Csf1r-related disorder	Enrichment	CSF1R	2.23
62	Rubinstein-taybi syndrome due to 16p13.3 microdeletion	Enrichment	CREBBP	2.23
63	Immunodeficiency 126	Enrichment	PTCRA	2.23
64	Thrombocytopenia with congenital dyserythropoietic anemia	Enrichment	GATA1	2.23
65	Chromosome 15q24 deletion syndrome	Enrichment	SIN3A	2.23
66	Agammaglobulinemia	Enrichment	SPI1	2.23
67	Isolated bone marrow mastocytosis	Enrichment	KIT	2.23
68	Smoldering systemic mastocytosis	Enrichment	KIT	2.23
69	Wilms tumor 7	Enrichment	TRIM28	2.23
70	Acute myeloid leukemia with mutated cebpa	Enrichment	CEBPA	2.23
71	Mastocytosis	Enrichment	KIT	2.23
72	Menke-hennekam syndrome	Enrichment	CREBBP	2.23
73	Familial progressive hyperpigmentation	Enrichment	KITLG	2.23
74	Early-onset calcifying leukoencephalopathy-skeletal dysplasia	Enrichment	CSF1R	2.23
75	Cutaneous mastocytoma	Enrichment	KIT	2.23
76	Typical urticaria pigmentosa	Enrichment	KIT	2.23
77	Nodular urticaria pigmentosa	Enrichment	KIT	2.23
78	Pseudoxanthomatous diffuse cutaneous mastocytosis	Enrichment	KIT	2.23
79	Telangiectasia macularis eruptiva perstans	Enrichment	KIT	2.23
80	Acute mast cell leukemia	Enrichment	KIT	2.23
81	Familial progressive hyper- and hypopigmentation	Enrichment	KITLG	2.23
82	Plaque-form urticaria pigmentosa	Enrichment	KIT	2.23
83	Neurocutaneous melanocytosis	Enrichment	NRAS	2.23
84	Bullous diffuse cutaneous mastocytosis	Enrichment	KIT	2.23
85	Testis seminoma	Enrichment	KIT	2.23
86	Inherited cancer-predisposing syndrome	Enrichment	CDKN1B, CDKN2A, CEBPA, KIT	2.12
87	Brittle bone disorder	Enrichment	COL1A2, WNT1	2.10
88	Myeloproliferative syndrome, transient	Enrichment	GATA1	1.93
89	Ectrodactyly and ectodermal dysplasia without cleft lip/palate	Enrichment	LEF1	1.93
90	Melanoma-astrocytoma syndrome	Enrichment	CDKN2A	1.93
91	Burkitt lymphoma	Enrichment	MYC	1.93
92	Cyclic neutropenia	Enrichment	ELANE	1.93
93	Hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome	Enrichment	GATA3	1.93
94	Bruck syndrome 1	Enrichment	COL1A2	1.93
95	Thumb deformity	Enrichment	CREBBP	1.93
96	Neutropenia, severe congenital, x-linked	Enrichment	ELANE	1.93
97	Porphyria, congenital erythropoietic	Enrichment	GATA1	1.93
98	Mitochondrial phosphate carrier deficiency	Enrichment	SLC25A3	1.93
99	Piebald trait	Enrichment	KIT	1.93
100	Osteogenesis imperfecta, type xv	Enrichment	WNT1	1.93
101	Melanoma, cutaneous malignant 2	Enrichment	CDKN2A	1.93
102	Ras-associated autoimmune leukoproliferative disorder	Enrichment	NRAS	1.93
103	Developmental and epileptic encephalopathy 28	Enrichment	MAF	1.93
104	Multiple endocrine neoplasia, type iv	Enrichment	CDKN1B	1.93
105	Spinocerebellar ataxia, autosomal recessive 12	Enrichment	MAF	1.93
106	Waardenburg syndrome, type 2f	Enrichment	KITLG	1.93
107	Ehlers-danlos syndrome, arthrochalasia type, 2	Enrichment	COL1A2	1.93
108	Intravascular large b-cell lymphoma	Enrichment	BCL2	1.93
109	Acute myeloid leukemia with kat6a-crebbp fusion	Enrichment	CREBBP	1.93
110	Split hand-foot malformation	Enrichment	LEF1	1.93
111	Melanoma-pancreatic cancer syndrome	Enrichment	CDKN2A	1.93
112	Witteveen-kolk syndrome	Enrichment	SIN3A	1.93
113	Angiocentric glioma	Enrichment	MYB	1.93
114	B-lymphoblastic leukemia/lymphoma with hyperdiploidy	Enrichment	GATA3	1.93
115	Hypoparathyroidism-deafness-renal disease syndrome	Enrichment	GATA3	1.93
116	Blepharophimosis - intellectual disability syndrome	Enrichment	SMARCA2	1.93
117	Ehlers-danlos/osteogenesis imperfecta syndrome	Enrichment	COL1A2	1.93
118	Autosomal dominant nonsyndromic deafness	Enrichment	GATA3	1.93
119	Cardiomyopathy-hypotonia-lactic acidosis syndrome	Enrichment	SLC25A3	1.93
120	Dentinogenesis imperfecta	Enrichment	COL1A2	1.93
121	B-lymphoblastic leukemia/lymphoma with t	Enrichment	KIT	1.93
122	B-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2)	Enrichment	PAX5	1.93
123	Bladder cancer	Enrichment	CDKN1A, CDKN2A	1.90
124	Prostate cancer	Enrichment	MAD1L1, ZFHX3	1.90
125	Severe combined immunodeficiency	Enrichment	ADA, RAG2	1.79
126	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency	Enrichment	ADA	1.75
127	Jacobsen syndrome	Enrichment	ETS1	1.75
128	Neutropenia, severe congenital, 1, autosomal dominant	Enrichment	ELANE	1.75
129	Combined cellular and humoral immune defects with granulomas	Enrichment	RAG2	1.75
130	Leukoencephalopathy, hereditary diffuse, with spheroids 1	Enrichment	CSF1R	1.75
131	Spinocerebellar ataxia 4	Enrichment	ZFHX3	1.75
132	Langerhans cell histiocytosis	Enrichment	NRAS	1.75
133	Osteoporosis, juvenile	Enrichment	WNT1	1.75
134	Tethered spinal cord syndrome	Enrichment	CREBBP	1.75
135	Large congenital melanocytic nevus	Enrichment	NRAS	1.75
136	Testicular germ cell cancer	Enrichment	KIT	1.75
137	Frontometaphyseal dysplasia	Enrichment	MAP3K7	1.75
138	Intraocular pressure quantitative trait locus	Enrichment	CREBBP	1.75
139	End stage renal disease	Enrichment	GATA3	1.75
140	Intellectual developmental disorder, autosomal dominant 30, with speech delay and behavioral abnormalities	Enrichment	ATP2B1	1.75
141	Adenoid cystic carcinoma	Enrichment	MYB	1.75
142	High bone mass osteogenesis imperfecta	Enrichment	COL1A2	1.75
143	Ovarian cancer	Enrichment	CDKN1B, CDKN2A, KIT	1.66
144	Ehlers-danlos syndrome, arthrochalasia type, 1	Enrichment	COL1A2	1.63
145	Schimmelpenning-feuerstein-mims syndrome	Enrichment	NRAS	1.63
146	Myeloperoxidase deficiency	Enrichment	MPO	1.63
147	Down syndrome	Enrichment	GATA1	1.63
148	Nicolaides-baraitser syndrome	Enrichment	SMARCA2	1.63
149	Infantile sialic acid storage disease	Enrichment	RAG2	1.63
150	Salla disease	Enrichment	RAG2	1.63
151	Mantle cell lymphoma	Enrichment	CCND1	1.63
152	Blepharophimosis	Enrichment	SMARCA2	1.63
153	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	NRAS	1.63
154	Smarca2-related nicolaides-baraitser syndrome	Enrichment	SMARCA2	1.63
155	Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)	Enrichment	KIT	1.63
156	Adenosine deaminase deficiency	Enrichment	ADA	1.63
157	Congenital blue dot cataract	Enrichment	MAF	1.63
158	Osteogenesis imperfecta with normal sclerae, dominant form	Enrichment	COL1A2	1.63
159	Primary hyperparathyroidism	Enrichment	CDKN1B	1.63
160	Systemic mastocytosis with associated hematologic neoplasm	Enrichment	KIT	1.63
161	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	MAT2A, SKI	1.56
162	Lymphoma, mucosa-associated lymphoid type	Enrichment	BIRC3	1.54
163	Amyloidosis, hereditary systemic 2	Enrichment	LYZ	1.54
164	Von hippel-lindau syndrome	Enrichment	CCND1	1.54
165	Mosaic variegated aneuploidy syndrome 1	Enrichment	MAD1L1	1.54
166	Goldberg-shprintzen syndrome	Enrichment	SKI	1.54
167	Follicular lymphoma	Enrichment	BCL2	1.54
168	Acute myeloid leukemia with maturation	Enrichment	KIT	1.54
169	Acute megakaryocytic leukemia	Enrichment	GATA1	1.54
170	Autosomal dominant severe congenital neutropenia	Enrichment	ELANE	1.54
171	Inherited acute myeloid leukemia	Enrichment	CEBPA	1.54
172	Free sialic acid storage disorder	Enrichment	RAG2	1.54
173	Ehlers-danlos syndrome, classic type, 1	Enrichment	COL1A2	1.46
174	Li-fraumeni syndrome	Enrichment	CDKN2A	1.46
175	Osteogenesis imperfecta, type i	Enrichment	COL1A2	1.46
176	Rubinstein-taybi syndrome 1	Enrichment	CREBBP	1.46
177	Split-hand/foot malformation 1	Enrichment	LEF1	1.46
178	Pierre robin syndrome	Enrichment	ATP2B1	1.46
179	Wilms tumor 5	Enrichment	TRIM28	1.46
180	Chromosome 16p13.3 deletion syndrome, proximal	Enrichment	CREBBP	1.46
181	Granulomatosis with polyangiitis	Enrichment	PRTN3	1.46
182	Adrenocortical carcinoma	Enrichment	CDKN2A	1.46
183	Lung squamous cell carcinoma	Enrichment	CDKN2A	1.46
184	Hypertrichosis	Enrichment	CREBBP	1.46
185	Classic ehlers-danlos syndrome	Enrichment	COL1A2	1.46
186	Nevus, epidermal	Enrichment	NRAS	1.39
187	Osteogenesis imperfecta, type ii	Enrichment	COL1A2	1.39
188	Thyroid cancer, nonmedullary, 2	Enrichment	NRAS	1.39
189	Gastrointestinal stromal tumor	Enrichment	KIT	1.39
190	Waardenburg syndrome, type 2e	Enrichment	KITLG	1.39
191	Leukemia, chronic myeloid	Enrichment	NRAS	1.39
192	Neutropenia	Enrichment	ELANE	1.39
193	Alzheimer's disease 1	Enrichment	MPO	1.39
194	Common variable immunodeficiency	Enrichment	RAG2	1.39
195	Follicular thyroid carcinoma	Enrichment	NRAS	1.39
196	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	CDKN2A	1.39
197	Myeloma, multiple	Enrichment	CCND1, CREBBP	1.37
198	Melanocytic nevus syndrome, congenital	Enrichment	NRAS	1.34
199	Mosaic variegated aneuploidy syndrome	Enrichment	MAD1L1	1.34
200	Cataract - microcornea syndrome	Enrichment	MAF	1.34
201	Leukemia, acute lymphoblastic 3	Enrichment	PAX5	1.29
202	Cataract 30, multiple types	Enrichment	MAF	1.24
203	Leukemia, chronic lymphocytic	Enrichment	CCND1	1.24
204	Melanoma	Enrichment	CDKN2A	1.24
205	Autosomal non-syndromic agammaglobulinemia	Enrichment	SPI1	1.24
206	Primary bone dysplasia	Enrichment	COL1A2	1.24
207	Immune deficiency disease	Enrichment	RAG2	1.20
208	Frontotemporal dementia 1	Enrichment	CSF1R	1.20
209	Osteochondrodysplasia	Enrichment	COL1A2	1.20
210	Lung non-small cell carcinoma	Enrichment	NRAS	1.20
211	Autism	Enrichment	ATP2B1, CREBBP	1.17
212	Juvenile myelomonocytic leukemia	Enrichment	NRAS	1.16
213	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	Enrichment	ATP2B1	1.13
214	Clubfoot	Enrichment	ATP2B1	1.13
215	Chromosome 1p36 deletion syndrome	Enrichment	SKI	1.13
216	Periventricular nodular heterotopia	Enrichment	ATP2B1	1.10
217	Heart disease	Enrichment	CREBBP	1.10
218	Pituitary stalk interruption syndrome	Enrichment	SMARCA2	1.10
219	Wilms tumor 1	Enrichment	TRIM28	1.07
220	Corpus callosum, agenesis of	Enrichment	CREBBP	1.07
221	Isolated corpus callosum agenesis	Enrichment	CREBBP	1.07
222	Rare genetic intellectual disability	Enrichment	CREBBP	1.07
223	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	CREBBP	1.07
224	Noonan syndrome and noonan-related syndrome	Enrichment	NRAS	1.07
225	Colorectal cancer	Enrichment	CCND1, NRAS	1.03
226	Melanoma, cutaneous malignant 1	Enrichment	CDKN2A	1.02
227	Diffuse large b-cell lymphoma	Enrichment	CREBBP	0.97
228	Ehlers-danlos syndrome	Enrichment	COL1A2	0.97
229	Diamond-blackfan anemia 1	Enrichment	GATA1	0.90
230	Noonan syndrome 1	Enrichment	NRAS	0.90
231	Autoinflammatory disease	Enrichment	ELANE	0.88
232	Scoliosis	Enrichment	CREBBP	0.88
233	Pancreatic cancer	Enrichment	CDKN2A	0.86
234	Developmental and epileptic encephalopathy 1	Enrichment	MAF	0.86
235	Rasopathy	Enrichment	NRAS	0.85
236	Differentiated thyroid carcinoma	Enrichment	NRAS	0.80
237	Primary autosomal recessive microcephaly	Enrichment	CDK6	0.76
238	Cakut	Enrichment	GATA3	0.74
239	Diamond-blackfan anemia	Enrichment	GATA1	0.72
240	Fetal akinesia deformation sequence 1	Enrichment	MYOD1	0.71
241	Systemic lupus erythematosus	Enrichment	ETS1	0.69
242	Benign epilepsy with centrotemporal spikes	Enrichment	MAF	0.67
243	Distal arthrogryposis	Enrichment	MYOD1	0.66
244	Centralopathic epilepsy	Enrichment	MAF	0.65
245	Gastric cancer	Enrichment	CDKN2A	0.65
246	West syndrome	Enrichment	MAF	0.64
247	Thrombocytopenia	Enrichment	GATA1	0.61
248	Autosomal dominant non-syndromic intellectual disability	Enrichment	PPP3CA	0.59
249	Rare autosomal dominant non-syndromic sensorineural deafness type dfna	Enrichment	KITLG	0.58
250	Undetermined early-onset epileptic encephalopathy	Enrichment	PPP3CA	0.55
251	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Enrichment	CSF1R	0.54
252	Congenital nervous system abnormality	Enrichment	CREBBP	0.33
253	Nervous system disease	Enrichment	CREBBP	0.33
254	Complex neurodevelopmental disorder	Enrichment	ATP2B1	0.28

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

C-MYB transcription factor network

Pathway Network for C-MYB transcription factor network

Member Pathways for C-MYB transcription factor network

Pathways in the C-MYB transcription factor network SuperPath

Associated Genes for C-MYB transcription factor network

Associated Disorders for C-MYB transcription factor network

Disorders associated with C-MYB transcription factor network SuperPath

STRING Interaction Network for C-MYB transcription factor network

Sources for C-MYB transcription factor network